Latest news

RCD – Rousaud Costas Duran has advised the biotech company Aelix Therapeutics on an €11.5M investment round; the money will be used to develop an effective vaccine against the HIV virus. Ysios Capital, a Spanish investment fund, led the round. The fundraising was also supported by Caixa Capital Risc and the American fund Johnson & Johnson Innovation.

Last Thursday, November 3, the Draft Law for the promotion of the ecosystem of emerging companies, known as the 'Start-ups Law', received the green light from Congress for its passage to the Senate